-
Clinical Outcomes of Early Diagnosis of Infections of Sterile Body Fluids: A Living Systematic Review and Meta Analysis
Sep 9, 2025, 16:22 PM -
Limited Duration vs. Treat-to-Progression Approaches for New Therapies in Hemato-oncology: Impact at HTA
Sep 9, 2025, 16:22 PM -
Regulatory Landscape Challenges and Trends in the Adoption of Digital Endpoints in Clinical Trials: A Scoping Review
Sep 9, 2025, 16:22 PM -
Comprehensive Clinical Evaluation of Drugs for Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Sep 9, 2025, 16:22 PM -
Leveraging a Multicountry Real-World Data Observatory to Monitor Respiratory Tract Infections and Evaluate Public Health Interventions in Europe
Sep 9, 2025, 16:22 PM -
Cost Savings From Patient Preference-Based Allocation of High-Efficacy Therapies for MS: Evidence From Switzerland
Sep 9, 2025, 16:22 PM -
Economic Evaluation of a Booster Dose of TDaP Vaccine to Adolescents in Spain
Sep 9, 2025, 16:22 PM -
A Novel Framework to Assess Noninferiority in National Institute for Health and Care Excellence (NICE) Cost-Comparison Evaluations (CCEs) Where Network Meta-Analyses (NMAs) Report Nonstatistically Significant Differences
Sep 9, 2025, 16:22 PM -
Estimating the Future Burden of Unvaccinated Girls Against Human Papilloma Virus (HPV) in Europe: A Modeling Study
Sep 9, 2025, 16:22 PM -
Correlation Between Ultra-Orphan Drug Costs Cost-Effectiveness Metrics and Disease Prevalence
Sep 9, 2025, 16:22 PM -
Budget Impact Minimization Approaches Used Across Europe, Brazil, and Japan in the Reimbursement of Obesity Medications
Sep 9, 2025, 16:22 PM -
Assessing the Budget Impact of Bimekizumab in the Management of Hidradenitis Suppurativa in France
Sep 9, 2025, 16:22 PM -
Gaps in JCA Guidance for Systematic Literature Reviews: A Comparative Review with Cochrane, EUnetHTA, and Major HTA Agencies' Standards
Sep 9, 2025, 16:22 PM -
Instrumental Variable Treatment Effects Estimation: A Simulation Comparison of Instrumental Variables and OLS Approaches
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness and Budget Impact of High-Dose Trivalent Influenza Vaccine Efluelda® in Older Adults: A Greek Healthcare System Perspective
Sep 9, 2025, 16:22 PM -
How Chinese Restaurants Can Help With Robust Preference Insights: A Novel Dirichlet Mixture Model to Account for Complex Heterogeneity in Individual Preference Weights
Sep 9, 2025, 16:22 PM -
Inequity in Public Healthcare Utilization Among Persons With Disabilities in Bangladesh: A Benefit Incidence Analysis
Sep 9, 2025, 16:22 PM -
Trends in Reimbursement Agreements for Innovative Orphan and Oncological Medicines in Spain 2020-2025
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of LGI-Flag in Austria: A Model-Based Evaluation
Sep 9, 2025, 16:22 PM -
Associations Between Waiting Time and Treatment Completion Among Treatment-Naive Pregnant Cannabis Users Admitted to Treatment Facilities in the United States
Sep 9, 2025, 16:22 PM
